BCAL Diagnostics Limited announced the appointment of experienced life science and healthcare executive Dr. John Hurrell as its Chief Executive Officer (CEO). Dr. Hurrell has developed and successfully commercialized multiple products and services in life sciences and diagnostics over a career in the industry spanning more than 35 years. He has developed and managed start-up and early-stage companies including successful life science companies based on university-developed technologies.

Most recently, he was Chief Commercial Officer at JanaCare, a remote chronic disease patient management company with a focus on diabetes and kidney disease. Dr Hurrell will commence the role on 14 February 2022. Dr Hurrell will divide his time between Australia and the USA, managing the current scientific and clinical activities based in Sydney, while at the same time preparing the company for future product launch in North America.